Apoptosis is very common during various stages of mammalian germ cell development and differentiation, and the BCL2 gene is one of the most important apoptotic regulators. Although its genetic variants are reported to be involved in cancers and autoimmune diseases, little information is available regarding BCL2 polymorphisms in male spermatogenesis. In the present study, single nucleotide polymorphisms (SNPs) in coding regions of the BCL2 gene were examined in a hospital-based, casecontrol study including 198 infertile patients with idiopathic azoospermia and 183 fertile controls. Subsequently, a functional study was conducted for comparison of paclitaxel-induced cytotoxicity and apoptosis between the BCL2 variant and the wild type in vitro. Three SNPs were found in exon 2-A21G (rs1801018), G127A (rs1800477), and C300T (rs61733416)-with the latter first reported in the Han-Chinese population. The frequency of G127A (GA+AA) genotype was significantly lower in azoospermic, infertile men compared to the age-matched controls (P ¼ 0.01). This genotype may confer a lower risk of azoospermia (adjusted odd ratio [OR] ¼ 0.448, 95% confidence interval ¼ 0.226-0.889). In addition, HeLa cells expressing the BCL2 Ala43Thr (G127A), similar to the control cells, were more sensitive to paclitaxel-induced cytotoxicity and apoptosis than those expressing wild-type BCL2. Consistently, the cleaved PARP and p-BCL2 proteins were subsequently increased after paclitaxel treatment, as also predicted by the bioinformatics analysis. Considering the decreased antiapoptotic function of BCL2, these results suggest that the Ala43Thr variant is associated with protection against azoospermia in the Han-Chinese population.
INTRODUCTION
Approximately 8-15% of human couples suffer from infertility, and about half of these cases are the result of male infertility [1] . Abnormal semen parameters, including low sperm motility (asthenozoospermia) and/or sperm count (oligozoospermia and azoospermia), account for 85% of male sterility [2] . Dyszoospermia can be caused by the interaction of genetic and environmental factors. Many environmental chemicals (e.g., endocrine disruptors, including pesticides, phthalates, and polycyclic aromatic hydrocarbons) may be associated with reproductive toxicity, such as declines in semen quality [3, 4] . However, genetic etiologies play a prominent role in male infertility, because up to 12% of men with nonobstructive azoospermia have chromosomal abnormalities [5] .
Mature sperm are the product of a precisely regulated network in which germ cell proliferation, differentiation, and apoptosis are carefully controlled [6] . Apoptosis occurs spontaneously throughout human spermatogenesis for the development of normal, mature spermatozoa and for the elimination of excess or abnormal germ cells, so the control of germ cell apoptosis is especially important [7] . During normal spermatogenesis, more than half of the germ cells undergo apoptosis, and 25-75% of the expected sperm yield is, indeed, thought to be lost during the first wave of spermatogenesis in pubertal mice [8] . Deregulation of apoptosis during spermatogenesis can disturb normal germ cell maturation, resulting in dyszoospermia (e.g., azoospermia). Of the genes involved in the regulation of apoptosis, BCL2, because of its function regarding inhibition of cell death in cancer development, may be the most studied [9] . Some studies have investigated the effect of misexpressing BCL2 in spermatogonia of transgenic mice and found that ectopically expressed BCL2 in spermatogonia inhibited their normal apoptosis [10] . As a result, abnormally accumulated spermatogonia failed to undergo further differentiation and survival, and they were deleted from the testis in transgenic mice with selective overexpression of BCL2 in the somatic cells of the testis [11] . These results indicated that spermatogonial apoptosis is part of the normal program of mammalian spermatogenesis and is regulated by a pathway affected by BCL2 [12] .
Because of the crucial role played by BCL2 in regulating apoptosis during spermatogenesis, polymorphisms or mutations of this gene might disturb normal spermatogenesis and result in azoospermia or oligozoospermia. An in vitro study discovered that the Ala43Thr variant in the BCL2 gene decreased antiapoptotic function and was associated with autoimmune diseases [13] . It has been speculated that variants or polymorphisms of the BCL2 gene can lead to modifications in the antiapoptotic function of this protein, resulting in an imbalance of cell homeostasis in general. Based on this hypothesis, some studies have focused on BCL2 polymorphisms in relation to cancers [14] and autoimmune diseases, such as systemic lupus erythematosus (SLE) [13] . To our knowledge, however, little information has been obtained regarding BCL2 genetic polymorphisms in male spermatogenesis.
In the present paper, we describe a case-control study on male infertility conducted in a Han-Chinese population to investigate the distribution of BCL2 gene polymorphisms in the coding regions and their association with azoospermia and to further examine their potential functions in antiapoptosis for spermatogenesis.
MATERIALS AND METHODS

Study Population
The infertile patients of the present study were consecutively recruited from the affiliated hospitals of Nanjing Medical University between April 2004 and July 2007 (Nanjing Medical University Infertility Study). All patients underwent semen analysis at least twice according to World Health Organization guidelines [15] and were diagnosed with idiopathic azoospermia after excluding all known causes [16] . Subjects who had special occupational exposure suspected to be associated with semen quality (e.g., exposure to pesticides or other agents) were also excluded. All subjects were Han Chinese and from Jiangsu and its neighboring provinces. They completed a questionnaire interview about demographics, medical history, genetic risk factors, and sexual and reproductive history. The cases in the present study involved 201 infertility patients with nonobstructive azoospermia (i.e., no sperm in semen even after centrifugation). The controls were frequencymatched to the cases by age (65 yr) and included 185 fertile men who had fathered at least one child without using assisted reproductive technologies and had normal spermatogenesis (sperm count, .20 3 10 6 sperm/ml). Individuals who smoked at least one cigarette per day for more than 1 yr were classified as ''ever smokers,'' and the others were classified as ''never smokers.'' Subjects who consumed one or more alcoholic drinks per week for at least 1 yr were classified as ''ever drinkers,'' and the others as classified as ''never drinkers.'' Each subject donated 5 ml of venous blood for genomic DNA extraction. The study was approved by the Institutional Review Board of Nanjing Medical University, and all participants signed an informed consent before participation in the study.
Genotype Analysis of BCL2 Exons
The leukocyte pellet was obtained from whole-blood samples by centrifugation of 5 ml of peripheral blood, and genomic DNA was extracted (DNA Preparation from Blood [2004] , Section of Cancer Genomics, Genetics Branch, NCI, National Institutes of Health). Considering that BCL2 coding regions were located in exons 2 and 3, the primer sets specific for the entire coding region (Fig. 1, P1 and P2, respectively) were designed based on GenBank sequence (accession no. AY220759), and the relevant regions were amplified by PCR using the following primers: P1 forward/reverse (5 0 !3 0 ), CGTCCAAGAATGCAAAGCAC/AGCCCAGACTCACATCACCA; P2 forward/reverse (5 0 !3 0 ), AGGATGCCTTTGTGGAAC/GCAAAAGGTTCAC TAAAGC. The PCR products were then purified using the Qiaquick gel extraction kit (Qiagen). Sequencing was performed from purified PCR products on an automated sequencer (ABI model 377 DNA analyzer; Applied Biosystems), and the sequences were analyzed by alignment with wild-type BCL2 DNA sequences.
For quality control, all samples that contained mutations were amplified and sequenced again to exclude PCR-introduced mutations, and 15% masked random samples were tested twice by different operators, with the results being consistent among all of the masked duplicate sets.
Establishment of HeLa Cells Expressing Wild-Type or Ala43Thr BCL2
Cell line and reagents. HeLa cells were purchased from American Type Culture Collection and were grown in Dulbecco modified Eagle medium supplemented with 10% FBS, 100 U/ml of penicillin, and 1 lg/ml of streptomycin (Life Technologies/Gibco) and incubated at 378C in 5% CO 2 (HERA Cell). Antibodies specific for rabbit anti-BCL2, BAX, TP53, poly(ADP-ribose) polymerase (PARP), and b-actin were obtained from Cell Signaling Technology. Hoechst 33258 was from Beyotime, Inc. Paclitaxel powder, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) dyes, and other chemicals used in the present study were purchased from Sigma. The stock solution of paclitaxel was prepared in PBS (pH 7.4).
Construction of expressing plasmids containing wild-type or Ala43Thr BCL2 cDNA. The pEGFP-C1-BCL2 expression vector containing wild-type BCL2 cDNA was a generous gift from Dr. Xuemin Zhang (Academy of Military Medical Sciences, Beijing, China), and the cDNAs were transferred into pcDNA3.1(þ) vector using XhoI and ApaI restriction enzymes and quick T4 DNA ligase and directly sequenced to exclude any extra mutation. Ala43Thr BCL2 cDNA were generated with site-directed mutagenesis according to the instructions from Stratagene. The PCR primers were designed using PrimerX software (http://bioinformatics.org/primerx) and synthesized by Invitrogen. The PCR products containing a single mutation (G127A) were obtained via amplification with the Pfu Ultra HF DNA Polymerase. The amplified full-length cDNA was always completely sequenced to ensure no extra mutations were included. To avoid possible extra mutations in the vector sequence produced during PCR-based mutagenesis, which may affect expression efficiency of the vector, the variant BCL2 cDNA was excised from the original vector after PCR amplification by XhoI and ApaI restriction enzymes and then reinserted into a fresh pcDNA3.1(þ) vector containing no mutations.
FIG. 1. PCR amplification of the coding regions of BCL2 gene. A)
Schematic diagram of the BCL2 gene and its isoforms. The primer P1 and P2 were designed to cover the coding regions for the a and b isoforms of BCL2. B) PCR products were visualized by electrophoresis. 1 and 2 represent exon 2 of the BCL2 gene, with a size of 639 bp; 3 and 4 represent exon 3 of the BCL2 gene, with a size of 185 bp; M1 and M2 represent the 500-bp and 100-bp DNA marker, respectively.
BCL2 Ala43Thr VARIANTS AND AZOOSPERMIA
Transfection of wild-type or Ala43Thr BCL2 cDNA in HeLa cells. Because of the low expression of BCL2, HeLa cells were used to establish the transfected cells. Cells were plated for 24 h at a density of 1 3 10 6 in 60-mm dishes and grew to 60-70% confluency, then were transfected by Lipofectamine 2000 (Invitrogen) with 8 lg of plasmids of wild-type or Ala43Thr BCL2 for 24 h. The vector alone was used as a negative control. Transfected efficiency was estimated from transient transfection of the pEGFP-C1 vector (Clontech) and averaged 90%. After removing the transfection mixture, the cells were incubated in complete medium for 8 h for recovery and then treated with or without paclitaxel for 24 h. Finally, the cells were harvested for analysis of BCL2 expression, proliferation, and apoptosis.
Cell Viability Assay (MTT Assay)
A total of 4000 cells were plated in 100 ll of the growth medium in 96-well plates and cultured at 378C in 5% CO 2 overnight, after which cells were transiently transfected with pcDNA 3.1(þ) vector containing wild-type or Ala43Thr BCL2 cDNA incubation for 24 h. After transfection, cells were pretreated with paclitaxel at concentrations of 0, 0.05, 0.1, 0.5, 1, and 5 lM for 24 h, and then 20 ll of MTT (1 mg/ml) were added to each well, which was followed by incubation at 378C in the dark for additional 4 h. The crystals were dissolved with 100 ll of DMSO, and the plates were read in a plate reader (Bio-TEK Instruments) at 490 nm.
Apoptosis Assay
Hoechst dying assay. Briefly, 6 3 10 5 transiently transfected cells were plated and treated with 0.1 lM paclitaxel for 24 h. The cells were washed twice in PBS for 5 min, then fixed in the 70% ethanol at 48C overnight. Following fixation, the cells were rinsed three times in PBS and then dyed with Hoechst 33258 (Beyotime Institute of Biotechnology, Shanghai, China; www.beyotime. com) for 5 min. The apoptotic cells were detected via Olympus inverted fluorescence microscope (IX70; Olympus).
Annexin V-FITC apoptosis detection. The Annexin V-FITC Apoptosis Detection Kit (BD PharMingen) was used for apoptosis detection according to the manufacturer's instructions. Briefly, after transiently transfected cells were prepared, the cells were incubated in the growth medium with 0.1 lM paclitaxel for 24 h. After treatment, the cells were harvested and washed twice with cold PBS, then resuspended in 400 ll of binding buffer at a concentration of 1 3 10 6 cells/ml. Next, 5 ll of Annexin V-FITC and 5 ll of propidium iodide were added to each tube, after which cells were incubated for an additional 5 min at 48C in the dark. The cells were analyzed by a FACScan flow cytometry (Becton Dickinson, Inc.).
Immunoblotting Assay
Transfection and paclitaxel treatments were prepared as previously mentioned, and then the total protein of HeLa cells was harvested for determination of expression. Immunoblotting assays were performed based on standard procedures (Shanghai ShineGene Molecular BioTech Ins.; http:// www.synthesisgene.com). Briefly, the cell lysate supernatants were obtained by centrifugation at 12 000 3 g for 15 min at 48C, and the pellets were discarded. After boiling for 5 min, 50 lg of protein were separated in 15% SDS-PAGE for 3 h, then transferred onto a polyvinylidene fluoride membrane (Millipore Corp.) and blocked in 5% nonfat milk in Tris-buffered saline þ 0.1% tween 20 (TBST) for 1 h. Subsequently, the sample was incubated with the specific primary antibodies overnight at 48C. After washing with TBST, the membranes were incubated with the horseradish peroxidase-conjugated secondary antibody for 1 h, then developed with an enhanced chemiluminescence immunoblotting assay kit (Cell Signaling Technology, Inc.) and exposed to Kodak X-Omat films. The immunoreactive bands were quantified using ImageJ software (http://rsb.info.nih.gov/ij) and normalized by b-actin bands of same membrane.
Statistical Analysis
Differences in select demographic variables, smoking status, alcohol use, the frequencies of the BCL2 genotypes and alleles between patients and controls were evaluated using the chi-square test. Multivariate logistic regression analysis was used to investigate the risk of idiopathic azoospermia after adjusting for potential confounding factors. Hardy-Weinberg equilibrium was tested by a goodness-of-fit chi-square test. The 2LD software was used to calculate the D 0 value for linkage disequilibrium (LD), and PHASE 2.0 was used to reconstruct haplotypes based on the detected BCL2 genotypes. Twoway ANOVA procedures were used to assess differences among groups. All 
RESULTS
Distribution of Selected Variables
Five samples failed to be amplified with PCR (three azoospermia patients and two controls), so the final samples included 198 azoospermia patients and 183 normal controls. The frequency distributions of sperm count, age, smoking status, and alcohol consumption among the study subjects are summarized in Table 1 . The average sperm density in controls was 53.6 3 10 6 sperm/ml. Although the age (mean 6 SD) of azoospermia patients was slightly older than that of controls (31.4 6 4.7 yr vs. 30.4 6 3.5 yr, P , 0.05), the difference was no more than 1 yr (consistent with our selected standard). The frequencies of smoking and drinking were similar in these two groups.
Frequency Distribution of BCL2 Genotypes
As shown in Figure 1A , there are three exons in BCL2 gene, of which exon 2 and exon 3 are coding sequences (BCL2a or BCL2b). Thus, these two exons were amplified to determine the BCL2 genotypes, and the corresponding PCR products were 639 bp (P1) and 185 bp (P2), respectively (Fig. 1B) . By direct sequencing, three SNPs in exon 2 of the BCL2 gene were screened: A21G (rs1801018) (Fig. 2A) , G127A (rs1800477) (Fig. 2B) , and C300T (rs61733416) (Fig. 2C) . C300T was first reported in the Han-Chinese population. Of these three SNPs, A21G and C300T were synonymous mutations, whereas G127A (Ala43Thr) was a missense mutation. Interestingly, no SNP was detected in exon 3.
Genotype frequencies of the detected SNPs in patients and controls, and their association with risk of azoospermia, are listed in Table 2 . All the SNPs were in agreement with the Hardy-Weinberg equilibrium (P ¼ 0.388 for A21G, 0.108 for G127A, and 0.591 for C300T). In fertile controls, the frequencies of variant genotypes were 14.7% for A21G (AG/ GG), 15.3% for G127A (GA/AA), and 7.7% for C300T (CT). All the SNPs in these three groups were almost heterozygous; no variant homozygote of C300T (TT) was found. Compared to the controls, the frequencies of these SNPs in the azoospermia patients were relatively low (8.6% for A21G, 7.1% for G127A, and 3.0% for C300T), and a significant difference in G127A was found between the azoospermia patients and the controls for Ala43Thr SNP (P ¼ 0.010 for the GAþAA genotype, P ¼ 0.034 for the GA genotype). Logistic regression analysis revealed that individuals carrying GA or AA genotypes of G127A had a lower risk of azoospermia (adjusted odd ratio [OR] ¼ 0.45, 95% confidence interval [CI] ¼ 0.23-0.89). Although the OR values of the genotype A21G (OR ¼ 0.55) and C300T (OR ¼ 0.38) in azoospermia were lower than unity, no significant differences were found (P ¼ 0.06 and 0.07, respectively).
Frequency Distribution of BCL2 Haplotypes
We performed haplotype inference on the three SNPs. The LD analysis suggested that the A21G locus was in LD with both the G127A locus (D 0 ¼ 1.000, P , 0.05) and the C300T locus (D 0 ¼ 1.000, P , 0.05). The G127A locus was also in LD 
Effects of Ala43Thr BCL2 on Paclitaxel-Induced Cytotoxicity and Apoptosis
As shown in Figure 3A , cells transfected with either wildtype or Ala43Thr BCL2 cDNA expressed comparable levels, whereas the level was very low in vector-only cells. Paclitaxel was used as inducer of proapoptosis to evaluate the potential difference among these cells. After paclitaxel treatment for 24 h, the cell viability in the two groups decreased in a dosedependent manner (Fig. 3B) . Compared with the wild type, however, the cells with Ala43Thr BCL2, similar to the vector control, were more sensitive to paclitaxel-induced toxicity; a significant difference from 0.5 lM paclitaxel was found (P , 0.05).
Based on the cytotoxicity assay, 0.1 lM paclitaxel was used to evaluate changes in the antiapoptotic ability of Ala43Thr BCL2. As shown in Figure 3C , the incidence of pyknotic cells among wild-type cells was much less than that among Ala43Thr BCL2 cells and vector cells. The incidence of pyknotic cells in Ala43Thr cells was 53.3%, similar to that in vector cells (57.7%) but significantly (P ¼ 0.01) higher than that in wild-type cells (44.4%) (Fig. 3D) . To confirm the results of morphologic analysis, apoptosis was determined using the Annexin V-FITC assay. The results were almost similar (Fig. 3 , E and F). The incidence of pyknotic cells with Ala43Thr BCL2 (36.2%) was converted to the vector cells (42.1%), both of which were significantly higher than cells with wild-type BCL2 (28.6%) (P , 0.05).
Effect of Ala43Thr BCL2 on Expression of Apoptosis-Related Proteins
To explore the mechanism for the changes in function of Ala43Thr BCL2, the apoptosis-related proteins, such as BAX, TP53, and cleaved PARP, were determined in the HeLa cells transfected with either wild-type or Ala43Thr BCL2 after treatment with 0.1 lM paclitaxel for 24 h. The proteins were detected by immunoblotting assay (Fig. 4A) . From the immunoreactive results of quantitatively cleaved PARP (Fig.  4B) , a caspase 3 substrate for which cleavage is indicative of activation of the apoptotic pathway, the cells with Ala43Thr BCL2 were less antiapoptotic to paclitaxel than the cells with wild-type BCL2. These results confirmed that the HeLa cells bearing Ala43Thr BCL2 protein showed a decreased antiapoptotic function, identical with a previous report [13] . In addition, the p-BCL2 protein in the cells with Ala43Thr BCL2 increased, which suggested that the Ala43Thr variant should be more phosphorylated than the wild-type BCL2 and, subsequently, have its antiapoptotic function decreased. However, no differences in terms of BAX or TP53 were found between cells carrying wild-type or Ala43Thr BCL2. 
660
DISCUSSION
In recent years, mutation screening and association studies on biomarkers of genetic susceptibility to complex diseases have revealed several exciting avenues regarding diagnostic, prognostic, and treatment aspects of infertility in human males [17] . SNPs in the BCL2 gene have also been detected in some disorders, including cancers [18] , autoimmune diseases [13] , and others [19] . A21G and G127A have been identified as two SNPs in the coding domains of the BCL2 gene. The available data reveal that the G127A-variant BCL2 has a reduced antiapoptotic function compared with wild-type BCL2 [13] . In the present study, our SNP screening analysis indicated three potential SNPs in this chromosomal region: A21G, G127A, and C300T. We found that although the distributions of all three genotypes were lower in azoospermia patients, only the genotypes (GA and GAþAA) of G127A were significant less prevalent (7.1%) than in controls (15.3%), which suggests that G127A may be associated with the reduced risk of azoospermia. Theoretically, A21G and C300T, both synonymous mutations, might contribute to the overall stability of the BCL2 transcript, efficiency of translation, and function of translated protein; however, the functions are not clear. Although it had been proposed for A21G that the modulation of the cell apoptosis of BCL2 was associated with increased BMI, A21G seemed not to be responsible for the association with cell apoptosis through a change in BMI levels [20] . The C300T polymorphism, a novel SNP in the Han-Chinese population, was unexpectedly identified in the current study; however, its obscure functional significance warrants further validation.
A growing body of evidences has demonstrated that apoptosis is the underlying mechanism of germ cell death, and human testes exhibit spontaneous occurrence of germ cell apoptosis involving all three classes of germ cells (spermatogonia, spermatocytes, and spermatids) [21] . Dysregulation of apoptosis during spermatogenesis could result in disturbance of germ cell maturation and spermatogenetic impairment. During spermatogenesis, the first wave is accompanied by extensive germ cell apoptosis. It is estimated that up to 75% of potential spermatozoa are lost through apoptosis in the testes of adult mammals [8] . BCL2 was expressed mainly in spermatogonia and early spermatocytes, which go through the first wave of spermatogenesis. During this process, BCL2 acts as an antiapoptotic protein, balancing the other family members, so its antideath function is vital for maintaining the number of germ cells that mature. Moreover, members of the BCL2 family of molecules, including BCL2, BCL2L1 (Bcl-xL), BCL2L2 (Bcl-w), and BAX, were involved in death/survival control of spermatogonia. Expression of the exogenous BCL2 protein, BCL2L2 deficiency, as well as BAX deficiency were associated with the apoptotic suppression of spermatogonia and led to lower numbers of germ cells of all types as well as Sertoli cells in adult testes [22, 23] . All the results indicated that the balance of anti-and proapoptotic functions of BCL2 family members is very important for maintaining normal spermatogenesis. Any deficiency of the BCL2 members would damage germ cell maturation and result in oligospermia, or even azoospermia. In the present study, it was speculated that Ala43Thr BCL2, via changing the interaction between BCL2 protein and its related family member, such as BCL2L1 and BCL2L2 as well as BAX, might modulate the balance of proand antiapoptosis to maintain normal spermatogenesis and should be associated with protection against azoospermia.
In agreement with some previous studies in cancer and autoimmune diseases, our present results showed that Ala43Thr BCL2 was commonly detected in the Han-Chinese population and that the BCL2 G127A (GAþAA) seemed to be associated with a lower risk for developing idiopathic azoospermia. The wild-type BCL2 genotype imposed significantly higher risk for developing esophageal cancer, particularly in an upper-and middle-third location [14] . In a Chinese study, the frequency of the GG genotype of G127A was higher in SLE patients than in controls. Consistent with these results, Komaki et al. [13] first found that G127A (GA/AA) of BCL2 conferred a relative resistance to autoimmune diseases in both children and adults. Those same authors also carried out an in vitro study of the Ala43Thr BCL2 variant, and the results showed that Ala43Ala BCL2 increased the survival of cells whereas the Ala43Thr variant acted as a suppressed haplotype for the antiapoptotic activity, which was consistent with the results of our functional study. Our findings of the significantly low frequency of G127A in azoospermia suggested that this variant may interfere in the balance of pro-and antiapoptosis   FIG. 4 . Effects of Ala43Thr BCL2 variant on paclitaxel-induced expression of the apoptosis related proteins. A) Expression of proteins such as p-BCL2 and BCL2, BAX, TP53, PARP, and cleaved PARP was determined by immunoblot analysis using their specific antibody. Cell lysate proteins (50 lg/lane) were prepared from the HeLa cells, and b-actin was used as internal reference. The bands were quantified using ImageJ software, and integrated intensity was calculated. All data are presented as relative ratio. B) For BAX and TP53, the relative values were the ratio of BAX or TP53 compared with the b-actin from the corresponding cells. For p-BCL2 and cleaved PARP, the relative values were the ratio of p-BCL2 or cleaved PARP compared with the total BCL2 or PARP, respectively. *P , 0.05, **P , 0.01 in comparison with the cells transfected with BCL2 G127A or vector alone.
BCL2 Ala43Thr VARIANTS AND AZOOSPERMIA during spermatogenesis and might be involved in a pathway to azoospermia different from the classical pathway, in which overapoptosis induces spermatogenic impairment, leading to azoospermia [23] . However, the precise role of Ala43Thr BCL2 in azoospermia has yet to be further elucidated.
The SNPs in BCL2 may modulate its physiological function, because the variants in the coding regions could change the amino acid of the protein. A flexible loop domain (FLD) was found within the BCL2 protein, which was considered as an important regulatory domain of BCL2 0 s posttranscriptive modulation [24, 25] . Biological research has revealed that mutations of phosphorylation residues located within the FLD of BCL2, including Thr-56, Ser-70, Thr-74, and Ser-87, could block its antiapoptotic function [26, 27] . One recent study supported that phosphorylation of these residues by JNK may be important for regulation of BCL2 function [28] . The current functional variant Ala43Thr located in the FLD region and its amino acid change could be a potential phosphorylation site. The present results showed that the variant BCL2 represented a slightly high level of phosphorylation and apoptotic cells (Fig.  4A ). This finding confirmed that Ala43Thr could be a phosphorylation site and that phosphorylation of this residue may reduce the antiapoptotic potential of BCL2. In addition, using Spark2 (donated by Dr. Yaoqi Zhou, Indiana University School of Informatics, Indianapolis, IN; http://sparks.informa tics.iupui.edu/) and Protein Explore (http://www. proteinexplorer.com), as well as RasMol software (http:// rasmol.org/OpenRasMol.html) as a bioinformatics tool, we confirmed that the Ala43Thr BCL2 protein revealed a conformational change, which reduces its ability to bind to the proapoptotic protein (e.g., BAX) and further decreases its antiapoptotic activity (data not shown). These observations could elucidate some underlying mechanisms for the functional alterations of the Ala43Thr BCL2. Consequently, it should be accepted that the equilibrium of apoptotic regulation during normal germ cell maturation is a key rationale for maintaining an appropriate number of sperm and that any impairment of this balance would result in disturbance of gametogenesis, causing azoospermia. Our findings might provide new etiological clues regarding infertility, especially azoospermia. However, further study is needed to elucidate the detailed mechanisms of this SNP and, potentially, to develop it as one of the diagnostic markers or therapeutic approaches for azoospermia in treating male infertility.
